Artificial intelligence could transform breast cancer detection and recurrence prediction

Artificial intelligence could transform breast cancer detection and recurrence prediction

https://www.eurekalert.org/news-releases/1134205

Publish Date: 2026-06-30 12:33:00

Source Domain: www.eurekalert.org

• Breast cancer prevalence and importance of early detection: Breast cancer remains one of the most common cancers among women, and early detection is critical in improving survival rates.

• Limitations of traditional breast cancer screening methods: Methods like mammography, MRI, ultrasound, and biopsy, have drawbacks, including false results, image interpretation variability, and high costs that can delay diagnosis.

• Benefits of AI in breast cancer screening: AI enhances conventional screening methods to improve early detection, reduce radiologist workload, increase diagnostic accuracy, and predict cancer recurrence effectively.

• Specific AI advancements in screening methods:

  • Mammography: AI-enhanced mammography detects more cancers without increasing false positives and reduces radiologist reading times by about 40%.
  • Three-dimensional imaging: AI detects more cancers (additional 1.6 per 1,000 screenings) and lowers patient recall rates.

• Applications of AI in MRI and ultrasound: AI in MRI assists in identifying future cancer risks a year before diagnosis. In ultrasound, AI improves diagnostic performance and reduces variability among radiologists.

• Role of AI in improving precision medicine: AI is used as a decision-support tool to identify imaging patterns, quantify tissue features, estimate recurrence risk, and prioritize findings needing further evaluation.

• Challenges for AI implementation: Issues such as single institutional data, lack of large-scale studies, cost-effectiveness, regulatory approval, and ensuring equitable access need addressing before widespread use.

• Future directions for AI in breast cancer management: Future research focuses on validating AI models in diverse populations, considering ethics, regulatory, and implementation factors to complement, not replace, clinician expertise.